General Practitioners and Participation Rate in ColoRectal Cancer Screening
AMDepCCR
Improving the Participation Rate in ColoRectal Cancer Screening by Training General Practitioners in Motivational Interviewing
2 other identifiers
interventional
902
1 country
53
Brief Summary
Colorectal cancer is the 2nd leading cause of cancer mortality in France. However this cancer is preventable in the majority of cases by early detection of adenomas. In France, there is organized colorectal cancer screening, which relies on general practitioners (GPs). Tests delivered by GPs are performed in 89% of cases. However, GPs do not systematically offer the test, for time management and communication reasons. Patients expect their GPs to offer the test and to focus on their expectations. A previous study conducted on GPs showed that training in communication and motivational interviewing increases the number of tests performed by 12.2%. In order to facilitate the promotion of screening, the investigators would like to develop a training programme for GPs focusing on the application of Motivational Interviewing (MI) techniques to the promotion of colorectal cancer screening. Motivational Interviewing is a directive, client-centered counseling style for eliciting behavior change by helping clients to explore and resolve ambivalence. This study is a multicenter trial in general medicine. In this randomized trial the 902 subjects will be included prospectively by the general practitioners (GP) participating in the study. As a first step, general practitioners who have never participated in Motivational Interviewing training will be recruited and split into 2 groups by randomization, an intervention group and a control group. The interventional group will then undergo a 3 times 2-day training in Motivational Interviewing. In a second step, the patients will be included by those GP and a self-questionnaire will be send at the inclusion and after 6, 12 and 24 months. The evaluation of the number of tests performed and the analyse of the Health Belief Model (HBM) self-questionnaire will be carried out. At 24 months, there will be an evaluation of the denial motivation questionnaire for patients who have not participated in organized colorectal cancer screening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable colorectal-cancer
Started May 2021
Typical duration for not_applicable colorectal-cancer
53 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2020
CompletedFirst Posted
Study publicly available on registry
July 30, 2020
CompletedStudy Start
First participant enrolled
May 31, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedApril 7, 2023
April 1, 2023
2 years
July 27, 2020
April 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of organised colorectal cancer screening at 24 months
The impact of training general practitioners in motivational interviewing on the rate of organised colorectal cancer screening will be assessed by determining whether or not the immunological test proposed as part of organised colorectal cancer screening at 24 months will be carried out.
24 months
Secondary Outcomes (4)
Rate of organised colorectal cancer screening at 12 months
12 months
Changes in perceptions of colorectal cancer screening
Day 0, 6 months, 12 months and 24 months
Evolution of the self-assessment of life expectancy
Day 0, 6 months, 12 months and 24 months
Identification of denial of the colorectal cancer screening
24 months
Study Arms (2)
Physicians trained in motivational interviewing
EXPERIMENTALPatients followed by general practitioners trained in motivational interviewing
Physicians did not trainned in motivational interviewing
NO INTERVENTIONPatients followed by general practitioners who did not receive motivational interviewing.
Interventions
Impact of the medical interview on the patient
Eligibility Criteria
You may qualify if:
- People with an average risk of colorectal cancer (presenting no symptoms or risk factors).
- People living in Finistère.
- People aged 50 to 74 who have never participated in organized screening for colorectal cancer.
You may not qualify if:
- Persons without address to receive the Health Belief Model (HBM)questionnaire
- People who do not fit the organized screening criteria
- Persons unable to give consent (patients under guardianship, curatorship, non-French speaking, illiterate)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (53)
Dr ABALAIN
Brest, 29200, France
Dr HENRY
Brest, 29200, France
Dr PETTON-HILI
Brest, 29200, France
Dr DENIEL
Châteauneuf-du-Faou, 29520, France
Dr LE BOURHIS
Châteauneuf-du-Faou, 29520, France
Dr PERRIER
Clohars-Carnoët, 29360, France
Dr CHAPOIX
Crozon, 29160, France
Dr OLIVIER
Daoulas, 29460, France
Dr ATTENCOURT
Douarnenez, 29100, France
Dr KERVELLA
Douarnenez, 29100, France
Dr VELLY
Ergué-Gabéric, 29500, France
Dr BLANCHARD
Esquibien, 29770, France
Dr DESNOT
Esquibien, 29770, France
Dr VIALA
Esquibien, 29770, France
Dr DAOUDAL
Fouesnant, 29170, France
Dr LEFEVRE
Fouesnant, 29170, France
Dr MAGADUR
Fouesnant, 29170, France
Dr MUNCK
Guerlesquin, 29650, France
Dr POINOT
Guerlesquin, 29650, France
Dr LE FLOCH
Guilvinec, 29730, France
Dr LE GRIGNOU
Guissény, 29880, France
Dr PITMAN
Landivisiau, 29400, France
Dr COLLETER
Lanmeur, 29260, France
Dr CRENN-CORVEZ
Lanmeur, 29260, France
Dr BECK-ROBERT
Lanmeur, 29620, France
Dr BARAIS
Lannilis, 29870, France
Dr VERBEQUE MORVAN
Le Conquet, 29217, France
Dr TREBAOL
Le Faou, 29590, France
Dr GRALL
Le Relecq-Kerhuon, 29480, France
Dr BOUTERAON
Loperhet, 29470, France
Dr PIPET-PENIN
Moëlan-sur-Mer, 29350, France
Dr BEURTON-COURAUD
Pleyben, 29190, France
Dr LUCAS
Pleyben, 29190, France
Dr KERFRIDEN KERHOAS
Pleyber-Christ, 29410, France
Dr BAUTA
Plonévez-Porzay, 29550, France
Dr COGNEAU
Plonévez-Porzay, 29550, France
Dr GASNIER
Ploudalmézeau, 29830, France
Dr AOUDIA
Plouezoc'h, 29252, France
Dr LOPIN
Plougonven, 29640, France
Dr DROGOU
Plouhinec, 29780, France
Dr BODIN
Plounéour-Trez, 29890, France
Dr DE LA SOUDIERE
Plouzané, 29280, France
Dr PETIT
Pont-l'Abbé, 29120, France
Dr PREVOT
Pouldreuzic, 29710, France
Dr AUTRET
Quimper, 29000, France
Dr COROLLER
Quimper, 29000, France
Dr COUTURIER
Quimper, 29000, France
Dr JOLIVET COUTURE
Quimper, 29000, France
Dr KERGASTEL
Quimper, 29000, France
Dr BARCELO
Saint-Martin-des-Champs, 29600, France
Dr MONFORT
Saint-Yvi, 29140, France
Dr MAILLEUCHET
Spézet, 29540, France
Dr NICOLAS
Trégunc, 29910, France
Related Publications (1)
Aujoulat P, Le Goff D, Dany A, Robaskiewick M, Nousbaum JB, Derrienic J, Cariou M, Guillou M, Le Reste JY. Improvement of participation rate in colorectal cancer (CRC) screening by training general practitioners in motivational interviewing (AmDepCCR). Trials. 2022 Feb 14;23(1):144. doi: 10.1186/s13063-022-06056-8.
PMID: 35164836DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The study is based on the participation of general practitioners in a training, the test is necessarily open for doctors. However patients will not know if their doctor has received training and will be blinded..
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2020
First Posted
July 30, 2020
Study Start
May 31, 2021
Primary Completion
May 31, 2023
Study Completion
May 31, 2025
Last Updated
April 7, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available beginning 42 months ending fifteen years following the final study report completion.
- Access Criteria
- Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.
All collected data that underlie results in a publication